Jack Harkness–Jane Glasson partnership

The partnership between Jack Harkness and Jane Glasson—also identified in the project as Astrid Townsend—drives the central scientific and ethical crisis of the story. They share the aim of preventing catastrophic climate change and build a pharmaceutical and nanotechnology program to pursue it; their solution, however, places a hidden, potentially uncontrollable mechanism within ordinary systems of medicine, food production, and infrastructure. When the alliance comes into view, its scale is inseparable from its secrecy and from the question of whether its partners can still control what they have set in motion.

Origins and shared purpose

The partnership is described as a sustained collaboration rather than a sudden response to the crisis. Filippo Crosetti says that Jack and Astrid brought him into their work twelve years earlier and persuaded him that their plan was right. He continues to understand the environmental danger that motivated them, even as he doubts the course they chose. Elsewhere, the project is described as having occupied roughly twenty years of Jane’s work with Harkness, and the closing account refers to the pair’s twenty years of planning. These time spans are presented in different contexts, but together establish an alliance with a long history and a project that outlasts any one immediate decision.

Their shared premise is that conventional reductions in emissions may not prevent severe consequences. Crosetti explains the carbon budget in concrete terms: to limit warming to two degrees above pre-industrial levels, emissions must fall to half their current level by 2050 and then reach zero; of an estimated total allowance of eight hundred gigatons, more than five hundred have already been used. At the current rate, he says, less than thirty years remain. He links that prospect not only to floods, storms, droughts, and famine but also to a sixth mass extinction. Jack, Astrid, and Crosetti are presented as agreeing that humanity must act, although agreement on the danger does not settle the moral status of their response.

Building the program through ordinary systems

Jack’s route into pharmaceuticals follows from the ambition of the plan: he believes the industry can provide a means to achieve the result they want. He recruits Astrid, then Crosetti, and together they develop the nanobot program. Its reach depends on routine exposure rather than a conspicuous new technology. Crosetti says that users of Harkness Pharmaceuticals’ medicines and cosmetics over the previous five years have nanobots in their bloodstream; exposure also extends to people who eat crops treated with the company’s pesticides or meat from animals given its antibiotics. Cosmetics, headache remedies, anti-malarials, pain relief, Elixtris, and Fenextris all belong to this network of products.

The nanobots eventually leave a person’s system, but Crosetti explains that continuing production replaces them. The program is thus not confined to a single device or a small group of participants: it is reproduced through factories and products used by millions. That breadth makes the partners’ pharmaceutical strategy effective on the scale they seek, while also making the technology difficult to distinguish from everyday life. Their environmental intervention is embedded in ordinary commercial circulation before its intended function is disclosed.

Wortalleth West and the Cascade mechanism

The partnership’s technical network also extends to Wortalleth West. The house has an independent power supply that Don Challenor learns was commissioned by Harkness: a solar array in a field about half a mile inland, supplemented by inconspicuous photovoltaic film on the south-facing walls of the house and garage. Harkness also purchased a large flow battery as backup. The scale of this system seems excessive to Don, and the battery’s whereabouts become a clue that the property contains concealed functions. Separately, the steel barrier is assessed as a possible sliding door to a two-floor chamber, although its independent cabling, pipes, air supply, and phone line cannot be traced. These features make the hidden room and the property’s unusual power arrangements part of the same widening mystery, without initially explaining their purpose.

Crosetti later identifies the room’s system as powerful enough to initialize Cascade. Doctor Tau has solved the problem of controlling nanobots from outside a host and triggering their designed function: one activation can set off a chain reaction among nanobots within ultrasonic range. Crosetti says that the system has overrides at Wortalleth West and in Locarno, known only to Harkness and himself. Without those controls, the process cannot be stopped once begun. Breaching the panic room is the trigger. The concealed architecture is therefore not merely a refuge or a source of private power: its opening is connected to the activation of a distributed technology already carried by people around the world.

Ideological fracture and the threatened consequence

Crosetti’s account makes clear that the partners’ shared objective has not produced equal conviction about their methods. He believes there may still be a chance to meet climate goals through a transition to renewable energy, and admits that he hoped to persuade Astrid to wait. He also believes that she and Jack will not wait: in his view, they have always been partners in the project, committed to acting without further hesitation. The disagreement is not over whether climate change and species loss matter, but over whether the catastrophic intervention they have devised is necessary and whether delay remains morally possible.

The treatment of Holly Walsh makes that conflict personal and immediate. Crosetti understands Astrid’s payment for Holly to obtain Ditrimantelline as an attempt to make her friend comfortable before the end, while also saying that the drug will kill her. He interprets Astrid’s separation from her family as a choice intended to preserve a clear view unclouded by conscience. This is Crosetti’s explanation of her reasoning, not a direct statement from Astrid, but it shows how he understands the cost of the partnership’s increasingly uncompromising logic: even care for a friend is subordinated to the anticipated catastrophe and the plan to address it.

Exposure, failure, and the partnership’s legacy

The question of identity is staged as part of the partnership’s secrecy. Blake tells Ingrid Denner that he wants to present his theory that the woman before them is Jane Glasson. The woman does not simply settle the matter; she invites Blake to explain his belief and tells Ingrid that she can judge for herself. In the later account of the project, Crosetti calls Harkness’s collaborator Astrid, while the closing narration refers to her as Astrid Townsend and says that the company may try to dismiss her as a consultant. The shifting names make disclosure itself part of the scene: the alliance is exposed through other people’s explanations before the woman’s own history is fully resolved in conversation.

Cascade is ultimately prevented from happening. After Harkness’s death, the company’s security team overrides the lock on the steel screen in his office; by then, the narrator believes, Jane has understood that the mechanism will not be activated. She leaves without speaking. The ending does not show her abandoning the project or beginning it again, but observes that she cannot restart something of this scale alone. The company may conceal the crisis and seek a deal with Quintagler Industries, while Crosetti has ensured that Harkness’s plan cannot work even if the panic room is opened. The partnership’s decisive legacy is therefore double: it has connected a sincere environmental alarm to a technology capable of immense, uncontrolled harm, and its immediate failure leaves one surviving partner to live with the collapse of a project built over decades.